18 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
of incorporation and failing to adopt the proposed Charter Amendment could impact our recruitment and retention of exceptional officer candidates that conclude
8-K
EX-99.2
zic03twopz65880
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
EX-99.2
08bwaww
14 May 19
Gossamer Bio Announces First Quarter 2019 Financial Results
7:31am
10-K
0wo2krfw3 14n
22 Mar 19
Annual report
4:45pm
424B4
g0505 0g6zdoxvqat
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
vz67cz
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
EX-10.5
blpo6
23 Jan 19
IPO registration (amended)
4:39pm
S-1
0o0d7bvqziyg dq3
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.5
4edh4ybc4jx0n
21 Dec 18
IPO registration
4:39pm
DRS/A
5ujhjhf
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
q7k3ue52
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next